Ann: ASX Confirms G Medical Delisting, page-330

$5M US - annual revenue with 2000 patients a month
$10M US - annual revenue with 4000 patients a month (July numbers)
$11M US - annual revenue with August numbers estimate
$330M US - 30xREV or NASDAQ price for a business like IRTC and Amwell
$30M US - capital raise at NASDAQ IPO at above pricing
$300M US - value of our current shareholding at NASDAQ$410M AUD - value of our current shareholding at NASDAQ
$0.48 AUD - value of one share of current shareholing (410/850)